Hacke, W <br/><br/>
Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.  [electronic resource] 

 -  Stroke  Oct 1998 
 - 2073-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0039-2499 
<br/><br/><label>Standard No.: </label>10.1161/01.str.29.10.2073  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cerebrovascular Disorders--drug therapy<br/>Humans<br/>National Institutes of Health (U.S.)<br/>Outcome Assessment, Health Care--statistics & numerical data<br/>Plasminogen Activators--therapeutic use<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Tissue Plasminogen Activator--therapeutic use<br/>United States